Literature DB >> 4400529

Effects of isoxazolium cations on some isolated muscle preparations.

T W Mittag, A Tormay.   

Abstract

1. The quaternary ammonium compound, N,t-butyl-5-methyl isoxazolium perchlorate (BIP), an anionic group reagent, initially causes contractions of the rat phrenic-nerve diaphragm, guinea-pig ileum and rabbit aortic strip preparations in vitro.2. In addition, the drug produces an irreversible block of indirectly elicited twitch responses in the diaphragm and of contractions induced by acetylcholine, methylfurmethide, dimethyl-phenylpiperazinium, 5-hydroxytryptamine (5-HT), histamine, angiotensin and pilocarpine in the ileum, while direct electrical stimulation of the diaphragm and contractions of the ileum to Ba and K ions are relatively unaffected.3. BIP is also an irreversible inhibitor of acetylcholinesterase but not of butyrylcholinesterase.4. On rabbit aortic strip preparations, responses to histamine, noradrenaline and 5-HT were differentially sensitive to irreversible blockade by BIP.5. Diphenhydramine, used in conditions which gave complete protection of the histamine response to irreversible block by dibenamine, did not protect against the blocking action of BIP but increased the blockade.6. These results suggest that BIP reacts covalently with anionic groups which mediate receptor initiated stimuli. The isoxazolium group may be useful in conferring irreversible properties by its substitution in drug molecules for the pyrrole or pyrrolidine group.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4400529      PMCID: PMC1665790          DOI: 10.1111/j.1476-5381.1971.tb07190.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

1.  Spiral-cut strip of rabbit aorta for in vitro studies of responses of arterial smooth muscle.

Authors:  R F FURCHGOTT
Journal:  Methods Med Res       Date:  1960

2.  Radiometric assay of cholinesterases in intact tissues in the nanomolar concentration range of acetylcholine.

Authors:  S Ehrenpreis; T W Mittag; P Patrick
Journal:  Biochem Pharmacol       Date:  1970-06       Impact factor: 5.858

3.  Affinity labeling of the acetylcholine-receptor.

Authors:  J P Changeux; T R Podleski; L Wofsy
Journal:  Proc Natl Acad Sci U S A       Date:  1967-11       Impact factor: 11.205

4.  A novel irreversible inhibitor of acetylcholinesterase specifically directed at the anionic binding site: structure-activity relationships.

Authors:  B Belleau; H Tani
Journal:  Mol Pharmacol       Date:  1966-09       Impact factor: 4.436

5.  The nature of an "anionic" site in butyrylcholinesterase compared with that of a similar site in acetylcholinesterase.

Authors:  K B Augustinsson
Journal:  Biochim Biophys Acta       Date:  1966-11-15

6.  Studies on the noradrenaline alpha-receptor. II. Analysis of the "spare-receptor" hypothesis and estimation of the concentration of alpha-receptors in rabbit aorta.

Authors:  M May; J F Moran; H Kimelberg; D J Triggle
Journal:  Mol Pharmacol       Date:  1967-01       Impact factor: 4.436

7.  Studies on the noradrenaline alpha-receptor. I. Techniques of receptor isolation. The distribution and specificity of action of N-(2-bromoethyl)-N-ethyl-1-naphthylmethylamine, a competitive antagonist of noradrenaline.

Authors:  J F Moran; M May; H Kimelberg; D J Triggle
Journal:  Mol Pharmacol       Date:  1967-01       Impact factor: 4.436

8.  An alkylating derivative of benzilylcholine with specific and long-lasting parasympatholytic activity.

Authors:  E W Gill; H P Rang
Journal:  Mol Pharmacol       Date:  1966-07       Impact factor: 4.436

9.  Acetylcholine receptor: covalent attachment of depolarizing groups at the active site.

Authors:  I Silman; A Karlin
Journal:  Science       Date:  1969-06-20       Impact factor: 47.728

10.  The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips.

Authors:  W D Paton; M A Zar
Journal:  J Physiol       Date:  1968-01       Impact factor: 5.182

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.